Mapping the relationship between genetics and the impact of aspirin on colorectal cancer

Bookmark and Share
Published: 3 Sep 2015
Views: 2266
Rating:
Save
Dr Hongmei Nan – Indiana University–Purdue University Indianapolis, Indiana, USA

Dr Hongmei Nan talks to ecancertv at the Aspirin Foundation meeting about the need for big, international and collaborative studies for better understanding genetic factors influencing the impact of aspirin on colorectal cancer.

For more on the Aspirin Foundation click here

Aspirin in the 21st century

Mapping the relationship between genetics and the impact of aspirin on colorectal cancer

Dr Hongmei Nan – Indiana University–Purdue University Indianapolis, Indiana, USA


If you want to identify some genetic variants that affect the aspirin and colorectal cancer relationship we need a very big data research because this kinds of research needs a strong statistical power to identify more convincingly the genetic factors. But this kind of study should be based on the collaborative studies, consortium studies, that’s why this study is successful. The major reason is this is a big collaborative study across the world. So I think in the future we need to consider, we need to promote, more collaborative team work like my study thereby we can identify more innovative and new findings so we help the clinical care like aspirin in colorectal cancer treatment.